Antibodies, Vol. 13, Pages 34: Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity Antibodies doi: 10.3390/antib13020034 Authors: Laura Rubio-Pérez Susana Frago Marta Compte Rocío Navarro Seandean L. Harwood Rodrigo Lázaro-Gorines Marina Gómez-Rosel Oana...

Antibodies, Vol. 13, Pages 33: Cross-Reactivity of N6AMT1 Antibodies with Aurora Kinase A: An Example of Antibody-Specific Non-Specificity Antibodies doi: 10.3390/antib13020033 Authors: Baiba Brūmele Evgeniia Serova Aleksandra Lupp Mihkel Suija Margit Mutso Reet Kurg Primary antibodies are one of the main tools...

Antibodies, Vol. 13, Pages 32: A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments Antibodies doi: 10.3390/antib13020032 Authors: Corrado Zengarini Alba Guglielmo Martina Mussi Giovanna Motta Claudio Agostinelli Elena Sabattini Bianca...

Antibodies, Vol. 13, Pages 31: Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy Antibodies doi: 10.3390/antib13020031 Authors: Karsten Beckmann Carmen Reitinger Xianglei Yan Anna Carle Eva Blümle Nicole Jurkschat Claudia Paulmann Sandra...

Antibodies, Vol. 13, Pages 30: Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation and Ultraviolet Photodissociation Antibodies doi: 10.3390/antib13020030 Authors: Eleanor Watts...

Antibodies, Vol. 13, Pages 29: Efficient Expression of Functionally Active Aflibercept with Designed N-glycans Antibodies doi: 10.3390/antib13020029 Authors: Tahereh Keshvari Stanislav Melnik Lin Sun Ali Niazi Farzaneh Aram Ali Moghadam Benjamin Kogelmann Gordana Wozniak-Knopp Somanath Kallolimath Amin Ramezani...